1. 2382. Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients: A Multi-Center Study. (26th November 2018) Authors: Elabor, Abdulrahman; Molnar, Esther; King, Madeline; Gallagher, Jason Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2435. Clinical Outcomes With Ceftolozane–Tazobactam in Patients With Multidrug-Resistant (MDR) Pseudomonas aeruginosa Bloodstream Infections: A Multi-Center Study. (26th November 2018) Authors: King, Madeline; Elabor, Abdulrahman; Molnar, Esther; Gallagher, Jason Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study. (31st October 2018) Authors: Gallagher, Jason C; Satlin, Michael J; Elabor, Abdulrahman; Saraiya, Nidhi; McCreary, Erin K; Molnar, Esther; El-Beyrouty, Claudine; Jones, Bruce M; Dixit, Deepali; Heil, Emily L; Claeys, Kimberly C; Hiles, Jon; Vyas, Nikunj M; Bland, Christopher M; Suh, Jin; Biason, Kenneth; McCoy, Dorothy; King... Journal: Open forum infectious diseases Issue: Volume 5:Number 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗